Dr. Vanderweele is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
251 E Huron St
Chicago, IL 60611
Education & Training
University of ChicagoFellowship, Hematology and Medical Oncology, 2009 - 2012- University of ChicagoResidency, Internal Medicine, 2007 - 2009
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2007
Certifications & Licensure
IL State Medical License 2009 - 2026- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- Management Decisions for Metastatic Castration-resistant Prostate Cancer in 2024.David J VanderWeele, Maha Hussain
European Urology. 2025-01-01 - Prolonged Response to Osimertinib in EGFR-Mutated Metastatic Urothelial Carcinoma, a Case Report.Sareen T Ali, David J VanderWeele
Current Oncology. 2024-07-14 - 2 citationsLarge Cell Neuroendocrine Prostate Cancer: Large Is Not Small.Anthony V Serritella, Himisha Beltran, Tamara L Lotan, David J VanderWeele, Fatima Karzai
The Oncologist. 2024-03-04
Press Mentions
Combination Treatment Extends Survival in Advanced Bladder CancerSeptember 17th, 2024- Combination Treatment Extends Survival in Locally Advanced Bladder CancerSeptember 15th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
